Ark is a specialist healthcare group with operations in the UK and Finland. Ark focuses on areas of high unmet clinical need in vascular disease and cancer, where opportunities exist for effective new products to generate significant revenues. With one marketed product, three further products in late stage clinical development and an advanced pipeline of follow-on opportunities, Ark is becoming recognised for the strength of its portfolio and for the consistent progress it makes in its business operations.
Converting science into products
Use the search form below to search our site.
Keep up-to-date with product developments, investor relations information and news with our email updates. Register here to receive our email alerts.
